TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26100002

Group type: EXPERIMENTAL
Intervention: HP gel + KTP laser irradiation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HP gel + Er:YAG irradiation
Number of subjects: 36

Group type: COMPARATOR
Intervention: HP gel without laser irradiation
Number of subjects: 36
Study: 23330721

Group type: EXPERIMENTAL
Intervention: 14-bp insertion/deletion polymorphism of HLA-G gene (dominant model)
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: 14-bp insertion/deletion polymorphism of HLA-G gene (codominant model)
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: 14-bp insertion/deletion polymorphism of HLA-G gene (dominant model after sensitivity analysis)
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: 14-bp insertion/deletion polymorphism of HLA-G gene (codominant model after sensitivity analysis)
Number of subjects: 1464
Study: 21485673

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral paracetamol
Number of subjects: 100
Study: 19910649

Group type: EXPERIMENTAL
Intervention: Acute exercise (45 min cycling at 65% heart-rate reserve)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No exercise
Number of subjects: 20
Study: 21735073

Group type: EXPERIMENTAL
Intervention: Suppressed smoking thoughts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expressed smoking thoughts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thinking about anything they wished
Number of subjects: 0
Study: 15821499

Group type: EXPERIMENTAL
Intervention: RTX 0.01 microM
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: RTX 0.05 microM
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: RTX 0.10 microM
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 12057987

Group type: EXPERIMENTAL
Intervention: 192Ir (catheter-based iridium-192)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 9843465

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 8005898

Group type: EXPERIMENTAL
Intervention: MDD group
Number of subjects: 79

Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 79
Study: 2492597

Group type: EXPERIMENTAL
Intervention: Human milk preparation (14 mL/kg/d for 2 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sterile water (14 mL/kg/d for 2 weeks)
Number of subjects: 16
Study: 133841

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TA)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 17-butyrate (HC 17-B)
Number of subjects: 19

Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 19
Study: 29927279

Group type: EXPERIMENTAL
Intervention: Distress Tolerance (DT) treatment
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard Treatment (ST)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both DT and ST treatments included transdermal nicotine patch and structured sessions.
Number of subjects: 116
Study: 27033012

Group type: EXPERIMENTAL
Intervention: tVNS (25 Hz)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (1 Hz)
Number of subjects: 76
Study: 24731061

Group type: EXPERIMENTAL
Intervention: Secondary alveolar bone graft (SABG)
Number of subjects: 50
Study: 22460472

Group type: EXPERIMENTAL
Intervention: High-load resistive exercise (n = 8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-load resistive exercise with whole-body vibration (n = 9)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No exercise (control, n = 9)
Number of subjects: 24
Study: 20542239

Group type: EXPERIMENTAL
Intervention: Long feedback from computerized alcohol intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short feedback from computerized alcohol intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Computerized intervention overall
Number of subjects: 0
Study: 18502363

Group type: EXPERIMENTAL
Intervention: Esmarch bandage
Number of subjects: 70

Group type: COMPARATOR
Intervention: Limb elevation
Number of subjects: 70
Study: 15952627

Group type: EXPERIMENTAL
Intervention: Fluoride drop group
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste group
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1200
Study: 11910265

Group type: EXPERIMENTAL
Intervention: Sertraline (50‐200 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 10515247

Group type: EXPERIMENTAL
Intervention: sCD30
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: sIL-2R
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: IL-1ra
Number of subjects: 10
Study: 7728829

Group type: EXPERIMENTAL
Intervention: Bicarbonate dentifrice with fluoride
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bicarbonate dentifrice without fluoride
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 10
Study: 2109464

Group type: EXPERIMENTAL
Intervention: Flumazenil (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (n = 40)
Number of subjects: 80
Study: 7390376

Group type: EXPERIMENTAL
Intervention: Tramal
Number of subjects: 23

Group type: COMPARATOR
Intervention: Pethidine
Number of subjects: 23
Study: 31230464

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Midazolam (control)
Number of subjects: 55
Study: 28658162

Group type: EXPERIMENTAL
Intervention: Individual recipes developed by a multidisciplinary team (nurses, doctors, dietitian, caregivers)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 110
Study: 26651467

Group type: EXPERIMENTAL
Intervention: 3 min after 30 SB min
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 6 min after 60 SB min
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 12 min after 120 SB min
Number of subjects: 30
Study: 24117926

Group type: EXPERIMENTAL
Intervention: Blinded evaluation of dermal changes in BCC
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Blinded evaluation of dermal changes in MIS
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Blinded evaluation of dermal changes in AK
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Overall blinded evaluation of dermal changes
Number of subjects: 301
Study: 21474477

Group type: EXPERIMENTAL
Intervention: Critical incident scenarios
Number of subjects: 15

Group type: COMPARATOR
Intervention: Uneventful anaesthesia induction
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Critical incident scenarios (experienced anaesthetists)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Critical incident scenarios (less experienced anaesthetists)
Number of subjects: 15
Study: 19164205

Group type: COMPARATOR
Intervention: Erlotinib 150 mg
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Erlotinib 300 mg
Number of subjects: 57
Study: 17364629

Group type: EXPERIMENTAL
Intervention: Single dose of superactivated charcoal (50 g)
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Multiple doses of superactivated charcoal (50 g, six doses q4h)
Number of subjects: 1103
Study: 14680739

Group type: EXPERIMENTAL
Intervention: bucindolol
Number of subjects: 2708

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2708
Study: 11075558

Group type: EXPERIMENTAL
Intervention: Target-controlled infusion (TCI) group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional continuous infusion (Cont group)
Number of subjects: 20
Study: 9176446

Group type: EXPERIMENTAL
Intervention: Transmyometrial ET
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transcervical ET
Number of subjects: 40
Study: 1300957

Group type: EXPERIMENTAL
Intervention: APSAC (30 mu in 5 mn)
Number of subjects: 183

Group type: COMPARATOR
Intervention: rt PA (10 mg bolus followed by 90 mg in 130 mn)
Number of subjects: 183
Study: 3840066

Group type: EXPERIMENTAL
Intervention: Acrivastine (BW825C) 4 mg, 8 mg, and 16 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Triprolidine HCl 2.5 mg and 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Acrivastine (BW825C)
Number of subjects: 12
Study: 30648677

Group type: EXPERIMENTAL
Intervention: GA + caudal epidural analgesia (Group I)
Number of subjects: 50

Group type: COMPARATOR
Intervention: GA + intravenous analgesia (Group II)
Number of subjects: 50
Study: 30098042

Group type: EXPERIMENTAL
Intervention: Pimodivir 600 mg with oseltamivir 75 mg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Pimodivir 600 mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 27086671

Group type: EXPERIMENTAL
Intervention: Azilsartan
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 60
Study: 24874893

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Adalimumab (dose-escalation subcohort)
Number of subjects: 79
Study: 23101763

Group type: EXPERIMENTAL
Intervention: Targeted cardiovascular case finding in intervention practices
Number of subjects: 6250

Group type: COMPARATOR
Intervention: Control practices
Number of subjects: 6250
Study: 20598967

Group type: EXPERIMENTAL
Intervention: Prasugrel + aspirin
Number of subjects: 10300

Group type: COMPARATOR
Intervention: Clopidogrel + aspirin
Number of subjects: 10300
Study: 18612426

Group type: EXPERIMENTAL
Intervention: 5 microg of Pfs25/ISA 51
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 5 microg of Pvs25/ISA 51
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 20 microg of Pvs25/ISA 51
Number of subjects: 36

Group type: COMPARATOR
Intervention: PBS/ISA 51 (adjuvant control)
Number of subjects: 36
Study: 15818103

Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (6 mL/kg of predicted body weight)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Higher tidal volume ventilation (12 mL/kg of predicted body weight)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Higher tidal volume ventilation
Number of subjects: 61
Study: 12596573

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anaesthesia (CSE), n = 20
Number of subjects: 40

Group type: COMPARATOR
Intervention: Balanced general anaesthesia (BGA) with controlled ventilation, n = 20
Number of subjects: 40
Study: 9787651

Group type: EXPERIMENTAL
Intervention: Behavioral intervention aimed at lifestyle changes in diet and physical activity
Number of subjects: 489

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 489
Study: 7634133

Group type: EXPERIMENTAL
Intervention: Delmopinol hydrochloride solution (2 mg/ml) rinsing for 60 s twice daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo rinsing
Number of subjects: 14
Study: 2792175

Group type: EXPERIMENTAL
Intervention: digoxin and concomitant treatment with urapidil 60 mg b.d.
Number of subjects: 12

Group type: COMPARATOR
Intervention: digoxin monotherapy
Number of subjects: 12
Study: 356508

Group type: EXPERIMENTAL
Intervention: Diazepam in polyethyleneoxydricinolate vehicle (Group A)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Diazepam in propyleneglycol‐ether alcohol vehicle (Group B)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Oral diazepam combined with intramuscular administration of vehicle used in Group B (Group C)
Number of subjects: 35
Study: 30964804

Group type: EXPERIMENTAL
Intervention: Condoms
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: PrEP
Number of subjects: 611
Study: 29668726

Group type: EXPERIMENTAL
Intervention: Movement-to-music video program (8 weeks)
Number of subjects: 71
Study: 27066730

Group type: EXPERIMENTAL
Intervention: PST + PE
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: PST
Number of subjects: 94

Group type: COMPARATOR
Intervention: EUC
Number of subjects: 94
Study: 24461403

Group type: EXPERIMENTAL
Intervention: MTA apical plug
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Regenerative endodontic protocol (blood clot)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Regenerative endodontic protocol (blood clot + injectable scaffold)
Number of subjects: 36
Study: 22261128

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (1 capsule daily for 3 months)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo (for 3 months)
Number of subjects: 95
Study: 20039078

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg kg(‐1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ketamine 1.0 mg kg(‐1)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ketamine (both doses)
Number of subjects: 45
Study: 17621653

Group type: EXPERIMENTAL
Intervention: GuardWire Plus
Number of subjects: 341

Group type: COMPARATOR
Intervention: Control
Number of subjects: 341
Study: 16353968

Group type: EXPERIMENTAL
Intervention: Gelled self-emulsifying formulation (SEF) containing ketoprofen (KPF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate release solid dosage form
Number of subjects: 0
Study: 12559482

Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP) 0.08 U/kg IM
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-dose physostigmine (PHYSO) 8 microg/kg IV
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Baseline plasma leptin concentrations
Number of subjects: 40
Study: 9848316

Group type: EXPERIMENTAL
Intervention: Cystectomy of the endometrioma (group 1)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Drainage of the endometrioma and bipolar coagulation of the inner lining (group 2)
Number of subjects: 64
Study: 8008533

Group type: EXPERIMENTAL
Intervention: Simethicone
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both Simethicone and Placebo
Number of subjects: 83
Study: 2480243

Group type: EXPERIMENTAL
Intervention: Human leukocyte interferon (IFN)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Streptozocin plus 5‐fluorouracil (chemotherapy)
Number of subjects: 20
Study: 19155900

Group type: EXPERIMENTAL
Intervention: Intracervical vasopressin (8 units)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (no injection)
Number of subjects: 58
Study: 229780

Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN) for 28 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN) for less than 9-14 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Intensive Nutritional Counseling (INC) and oral supplementation
Number of subjects: 28
Study: 31868126

Group type: EXPERIMENTAL
Intervention: Agency assigned to the virus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High marking of argumentative orientation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Agency assigned to humans
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low marking of argumentative orientation
Number of subjects: 0
Study: 30994576

Group type: EXPERIMENTAL
Intervention: Vaginal 10 μg estradiol tablet plus placebo gel (n = 102)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Placebo tablet plus vaginal moisturizer (n = 100)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Dual placebo (n = 100)
Number of subjects: 302
Study: 28341129

Group type: EXPERIMENTAL
Intervention: Hand washing with alcohol gel only up to elbows (Group A)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Hand washing with soap up to elbows, sterile towel to dry, followed by alcohol gel (Group B)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Hand washing with soap up to elbows, non‐sterile towel to dry, followed by alcohol gel (Group C)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Hand washing with soap up to elbows, non‐sterile towel to dry (Group D)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Hand washing with soap up to elbows, sterile towel to dry (Group E)
Number of subjects: 5
Study: 26923921

Group type: EXPERIMENTAL
Intervention: Hydrogel contact lens wear for 8 hours
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (non-lens-wearing eye)
Number of subjects: 10
Study: 24418055

Group type: EXPERIMENTAL
Intervention: ABT-384 10 mg once daily
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: ABT-384 50 mg once daily
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Donepezil 10 mg once daily
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 22048324

Group type: EXPERIMENTAL
Intervention: L-arginine (4.25 mmol L(‐1))
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: L-glutamine (45 mmol L(‐1))
Number of subjects: 8

Group type: COMPARATOR
Intervention: Glucose only
Number of subjects: 8

Group type: COMPARATOR
Intervention: No glucose
Number of subjects: 8
Study: 19250060

Group type: EXPERIMENTAL
Intervention: Teriparatide 20 microg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17488518

Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 d1 and cisplatin 75 mg/m2 d1, q 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vinorelbine and cisplatin regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pemetrexed and cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vinorelbine and cisplatin
Number of subjects: 0
Study: 15086477

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU/day)
Number of subjects: 993

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 993
Study: 12127641

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally followed by misoprostol 0.8 mg orally or vaginally 36-48 hours later
Number of subjects: 123
Study: 9667273

Group type: EXPERIMENTAL
Intervention: 10 mg methylphenidate twice daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 20 mg methylphenidate twice daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 30 mg methylphenidate twice daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: methylphenidate treatment
Number of subjects: 30
Study: 8137524

Group type: EXPERIMENTAL
Intervention: 10 mg cetrorelix
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 2 mg cetrorelix
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5 mg cetrorelix
Number of subjects: 16
Study: 2551084

Group type: EXPERIMENTAL
Intervention: Intervention group (visited by health visitors post-discharge)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (received usual offers of assistance)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 135
Study: 1042713

Group type: EXPERIMENTAL
Intervention: Sensory information group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Procedure information group
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: No pre-fear group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Some pre-fear group
Number of subjects: 84
Study: 29787478

Group type: EXPERIMENTAL
Intervention: Progressive resistance training program with elastic bands (12 months, six exercises, three sets × 10 repetitions)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 38
Study: 27997669

Group type: EXPERIMENTAL
Intervention: Dynamic air exchange (DAE) prosthesis
Number of subjects: 5

Group type: COMPARATOR
Intervention: Total surface bearing suction socket (Suction) prosthesis
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Both prostheses
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Questionnaire results
Number of subjects: 5
Study: 25518578

Group type: EXPERIMENTAL
Intervention: Patients without depressive symptoms
Number of subjects: 100

Group type: COMPARATOR
Intervention: Patients with mild depressive symptoms (40% of patients)
Number of subjects: 100
Study: 22891232

Group type: EXPERIMENTAL
Intervention: FSV/TPGS preparation coadministered with additional vitamin K
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: FSV/TPGS preparation
Number of subjects: 92
Study: 20543018

Group type: EXPERIMENTAL
Intervention: On-call physical therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Regular physical therapy (Control)
Number of subjects: 38
Study: 17720303

Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Moderate atherosclerosis (no specific treatment mentioned)
Number of subjects: 8
Study: 15925748

Group type: EXPERIMENTAL
Intervention: Essential amino acids (EAA) for 4 months
Number of subjects: 25

Group type: COMPARATOR
Intervention: L-NMMA (intra-arterial infusion of 4 micromol/min)
Number of subjects: 25
Study: 12885701

Group type: EXPERIMENTAL
Intervention: Bread and cookies rich in beta-glucan (5.9 g/day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Orange juice containing beta-glucan (5 g/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control bread and cookies rich in wheat fiber
Number of subjects: 48
Study: 11099445

Group type: EXPERIMENTAL
Intervention: Patients with Parkinson's disease
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 25
Study: 8993769

Group type: EXPERIMENTAL
Intervention: Transfer factor (TF) treatment
Number of subjects: 99

Group type: COMPARATOR
Intervention: Non-treated controls
Number of subjects: 99
Study: 1482265

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors (CEI)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Calcium antagonists (CA)
Number of subjects: 236
Study: 3912334

Group type: EXPERIMENTAL
Intervention: 400 mg i.v. indoprofen
Number of subjects: 40

Group type: COMPARATOR
Intervention: 10 mg i.m. morphine hydrochloride
Number of subjects: 40
Study: 31679509

Group type: COMPARATOR
Intervention: Intermittent boluses (1.5 mcg/Kg phenylephrine)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Fixed on-and-off infusion (0.75 mcg/Kg/min)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Variable infusion (0.75 mcg/Kg/min)
Number of subjects: 217
Study: 30153993

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ramipril (subgroup with right ventricular restrictive physiology)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64